Earlier in December 2025, Recursion Pharmaceuticals reported positive Phase 1b/2 TUPELO trial data for REC-4881 in familial adenomatous polyposis, showing rapid and durable reductions in polyp burden ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Interested in a perfect high-performance Chevy sedan with a mere 79 miles on the odometer and an interior that's still partially wrapped in plastic? Remarkably, you can have one: this Impala SS was ...

One of the last examples of the full-size, body-on-frame American sedan is a nostalgic blast from the past. This 1996 Chevrolet Impala SS is a low-mileage, seventh-generation B-body sedan up for ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Currents haunts Tame Impala like a ghost. Or an ex who won’t leave you alone. Since its release ten years ago, it’s become the de facto control against which to measure all of Kevin Parker’s releases ...

The last couple decades have been lousy with bearded musical visionaries. Yet despite all that heavy traffic, Tame Impala‘s Kevin Parker has easily carved own his own unique lane. He’s the Australian ...